These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27499890)

  • 1. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
    Howat WJ; Blows FM; Provenzano E; Brook MN; Morris L; Gazinska P; Johnson N; McDuffus LA; Miller J; Sawyer EJ; Pinder S; van Deurzen CH; Jones L; Sironen R; Visscher D; Caldas C; Daley F; Coulson P; Broeks A; Sanders J; Wesseling J; Nevanlinna H; Fagerholm R; Blomqvist C; Heikkilä P; Ali HR; Dawson SJ; Figueroa J; Lissowska J; Brinton L; Mannermaa A; Kataja V; Kosma VM; Cox A; Brock IW; Cross SS; Reed MW; Couch FJ; Olson JE; Devillee P; Mesker WE; Seyaneve CM; Hollestelle A; Benitez J; Perez JI; Menéndez P; Bolla MK; Easton DF; Schmidt MK; Pharoah PD; Sherman ME; García-Closas M
    J Pathol Clin Res; 2015 Jan; 1(1):18-32. PubMed ID: 27499890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium.
    Abubakar M; Howat WJ; Daley F; Zabaglo L; McDuffus LA; Blows F; Coulson P; Raza Ali H; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Tollenaar RA; Devilee P; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Wm Martens J; Hm van Deurzen C; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Broeks A; van Leeuwen FE; Van't Veer L; Swerdlow AJ; Orr N; Dowsett M; Easton D; Schmidt MK; Pharoah PD; Garcia-Closas M
    J Pathol Clin Res; 2016 Jul; 2(3):138-53. PubMed ID: 27499923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
    Bolton KL; Garcia-Closas M; Pfeiffer RM; Duggan MA; Howat WJ; Hewitt SM; Yang XR; Cornelison R; Anzick SL; Meltzer P; Davis S; Lenz P; Figueroa JD; Pharoah PD; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):992-9. PubMed ID: 20332278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
    Abubakar M; Orr N; Daley F; Coulson P; Ali HR; Blows F; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Devilee P; Tollenaar RA; Seynaeve C; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Wesseling J; van Leeuwen FE; Van 't Veer L; Easton D; Swerdlow AJ; Dowsett M; Pharoah PD; Schmidt MK; Garcia-Closas M
    Breast Cancer Res; 2016 Oct; 18(1):104. PubMed ID: 27756439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry scoring of breast tumor tissue microarrays: A comparison study across three software applications.
    Baker GM; Bret-Mounet VC; Wang T; Veta M; Zheng H; Collins LC; Eliassen AH; Tamimi RM; Heng YJ
    J Pathol Inform; 2022; 13():100118. PubMed ID: 36268097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
    Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA
    Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
    J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    J Clin Pathol; 2007 Apr; 60(4):397-404. PubMed ID: 16775123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
    Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW
    Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of breast cancer subtypes among African American women in the AMBER consortium.
    Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA
    Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.
    Quintayo MA; Starczynski J; Yan FJ; Wedad H; Nofech-Mozes S; Rakovitch E; Bartlett JM
    Histopathology; 2014 Jul; 65(1):2-8. PubMed ID: 24267587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
    Turbin DA; Leung S; Cheang MC; Kennecke HA; Montgomery KD; McKinney S; Treaba DO; Boyd N; Goldstein LC; Badve S; Gown AM; van de Rijn M; Nielsen TO; Gilks CB; Huntsman DG
    Breast Cancer Res Treat; 2008 Aug; 110(3):417-26. PubMed ID: 17912629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.
    Qaiser T; Mukherjee A; Reddy Pb C; Munugoti SD; Tallam V; Pitkäaho T; Lehtimäki T; Naughton T; Berseth M; Pedraza A; Mukundan R; Smith M; Bhalerao A; Rodner E; Simon M; Denzler J; Huang CH; Bueno G; Snead D; Ellis IO; Ilyas M; Rajpoot N
    Histopathology; 2018 Jan; 72(2):227-238. PubMed ID: 28771788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.
    Loughrey MB; Bankhead P; Coleman HG; Hagan RS; Craig S; McCorry AMB; Gray RT; McQuaid S; Dunne PD; Hamilton PW; James JA; Salto-Tellez M
    Histopathology; 2018 Aug; 73(2):327-338. PubMed ID: 29575153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
    Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
    Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes.
    Kildal W; Cyll K; Kalsnes J; Islam R; Julbø FM; Pradhan M; Ersvær E; Shepherd N; Vlatkovic L; ; Tekpli X; Garred Ø; Kristensen GB; Askautrud HA; Hveem TS; Danielsen HE;
    Heliyon; 2024 Jul; 10(13):e32529. PubMed ID: 39040241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.
    Marotti JD; Collins LC; Hu R; Tamimi RM
    Mod Pathol; 2010 Feb; 23(2):197-204. PubMed ID: 19898422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
    Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
    Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.